Sub menu

 
 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

1062 result(s) found, displaying 901 to 925

  • AusPAR: Octreotide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Octreotide

  • AusPAR: Cabazitaxel

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Cabazitaxel

  • AusPAR: Fibrin adhesive/sealant

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Fibrin adhesive/sealant

  • AusPAR: Rasagiline

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Rasigiline

  • AusPAR: Ciclesonide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ciclesonide

  • AusPAR: Roflumilast

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Roflumilast

  • AusPAR: Linagliptin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Linagliptin

  • AusPAR: Rituximab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Rituximab

  • AusPAR: Tocilizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Tocilizumab

  • AusPAR: Ranibizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ranibizumab

  • AusPAR: Bortezomib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Bortezomib

  • AusPAR: Denosumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Denosumab

  • AusPAR: Prucalopride

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Prucalopride

  • AusPAR: Cyclosporin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Cyclosporin

  • AusPAR: Naproxen / Esomeprazole

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Naproxen / Esomeprazole

  • AusPAR: Ranibizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ranibizumab

  • AusPAR: Cetuximab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Cetuximab

  • AusPAR: Dexamethasone

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Dexamethasone

  • AusPAR: Sildenafil

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Sildenafil

  • AusPAR: Filgrastim

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Filgrastim

Help us improve the Therapeutic Goods Administration site